« Previous
Next »
The Breast
Volume 19, Issue 6
, Pages 484-488
, December 2010
Hypomethylation of the interleukin-10 gene in breast cancer tissues
References
- . Cytokines in cancer immunity and immunotherapy. Immunological Reviews. 2004;202:275–293
- . High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours. British Journal of Cancer. 1997;75(12):1826–1830
- IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. Journal of Immunology. 1991;146(10):3444–3451
- . Interleukin-10. Annual Review of Immunology. 1993;11:165–190
- Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers. Journal of Immunology. 1999;162(8):4882–4892
- Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Research. 1995;55(17):3847–3853
- Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Human Molecular Genetics. 2005;14(2):319–326
- . The history of cancer epigenetics. Nature Reviews. 2004;4(2):143–153
- Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancer. Oncology Reports. 2008;19(3):663–668
- Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma. Laboratory Investigation. 2001;81(4):573–579
- . Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. Journal of Biological Chemistry. 2004;279(30):31735–31744
- . Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. Journal of Biological Chemistry. 2002;277(44):41571–41579
- . Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma. Clinical Cancer Research. 2004;10(9):3035–3041
- Promoter methylation of cyclin D2 gene in gastric carcinoma. International Journal of Oncology. 2003;23(6):1663–1670
- . Promoter-dependent mechanism leading to selective hypomethylation within the 5’ region of gene MAGE-A1 in tumor cells. Molecular and Cellular Biology. 2004;24(11):4781–4790
- Demethylation of MAGE promoters during gastric cancer progression. British Journal of Cancer. 2004;90(4):838–843
- . Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. Journal of Interferon Cytokine Research. 1999;19(7):697–703
- Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood. 2000;96(7):2568–2573
- Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. International Journal of Cancer. 1997;74(5):492–501
- . Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. International Journal of Cancer. 2008;123(4):780–786
- . Tumour-associated leucocytes: friends or foes in breast carcinoma. Journal of Pathology. 1994;172(3):229–235
PII: S0960-9776(10)00143-8
doi: 10.1016/j.breast.2010.05.011
© 2010 Elsevier Ltd. All rights reserved.
« Previous
Next »
The Breast
Volume 19, Issue 6
, Pages 484-488
, December 2010
